Lenograstim reduces the incidence of febrile episodes, when compared with filgrastim, in multiple myeloma patients undergoing stem cell mobilization-Reference-Cited by-同舟云学术

Lenograstim reduces the incidence of febrile episodes, when compared with filgrastim, in multiple myeloma patients undergoing stem cell mobilization

Published:2011-07 Issue:7 Volume:35 Page:899-903
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Orciuolo Enrico,Buda Gabriele,Marturano Emerenziana,Mauro Elisa,Milone Giuseppe,Cangialosi Clotilde,Di Renzo Nicola,Pastore Domenico,Specchia Giorgina,De Paolis Maria Rosaria,Mazza Patrizio,Pietrantuono Giuseppe,Petrini Mario

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference19 articles.

1. Hematopoietic stem-cell transplantation;Copelan;N Engl J Med,2006

2. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma;Child;N Engl J Med,2003

3. Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation;Narayanasami;Blood,2001

4. Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trial;Abdelkefi;Blood,2008

5. Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on stem cell collection in multiple myeloma;Mark;Biol Blood Marrow Transplant,2008

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122);Cancer Medicine;2023-03-23

2. Clinical implications, safety, efficacy of Recombinant Human Granulocyte Colony-Stimulating Factors and Pegylated Equivalent;Epidemiology, Biostatistics, and Public Health;2022-07-04

3. Efficacy of hematopoietic stem cell mobilization regimens in patients with hematological malignancies: a systematic review and network meta-analysis of randomized controlled trials;Stem Cell Research & Therapy;2022-03-22

4. Advances in the pharmacological management of neutropenia in solid tumors: the advent of biosimilars;Expert Opinion on Pharmacotherapy;2021-02-12

Monocentric Analysis of the Effectiveness and Financial Consequences of the Use of Lenograstim versus Filgrastim for Mobilization of Peripheral Blood Progenitor Cells in Patients with Lymphoma and Myeloma Receiving Chemotherapy and Autologous Stem Cell Transplantation

;Journal of Blood Medicine;2020-04